Related references
Note: Only part of the references are listed.Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
Camilla Bockelman et al.
ACTA ONCOLOGICA (2015)
Acta Oncologica and a new generation of scientists in oncology
Bengt Glimelius et al.
ACTA ONCOLOGICA (2014)
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
Christina Therkildsen et al.
ACTA ONCOLOGICA (2014)
The total number of lymph nodes in resected colon cancer specimens is affected by several factors but the lymph node ratio is independent of these
Luka Stanisavljevic et al.
APMIS (2014)
Implementation of complete mesocolic excision at a university hospital in Denmark: An audit of consecutive, prospectively collected colon cancer specimens
D. L. E. Munkedal et al.
EJSO (2014)
The role of adjuvant chemotherapy in stage II colorectal cancer patients
Hung-Hsin Lin et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery
K. Sondenaa et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Pathology is a necessary and informative tool in oncology clinical trials
Iris D. Nagtegaal et al.
JOURNAL OF PATHOLOGY (2014)
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Julien Taieb et al.
LANCET ONCOLOGY (2014)
Identification of Clinically Relevant Molecular Subtypes in Colorectal Cancer: The Dawning of a New Era
Patrick G. Johnston
ONCOLOGIST (2014)
Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan
Anne Norgaard et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008
Colette B. M. van den Broek et al.
ACTA ONCOLOGICA (2013)
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study
Francesco Iachetta et al.
ACTA ONCOLOGICA (2013)
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series
M. A. Merok et al.
ANNALS OF ONCOLOGY (2013)
Anticipating the Clinical Use of Prognostic Gene Expression-Based Tests for Colon Cancer Stage II and III: Is Godot Finally Arriving?
Anita Sveen et al.
CLINICAL CANCER RESEARCH (2013)
Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer
J. Arredondo et al.
COLORECTAL DISEASE (2013)
Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort
B. S. Nedrebo et al.
COLORECTAL DISEASE (2013)
Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database
Nadine J. McCleary et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database
Qian Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam et al.
NATURE MEDICINE (2013)
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status
Thierry Andre et al.
CURRENT COLORECTAL CANCER REPORTS (2013)
Adjuvant chemotherapy in stage III colon cancer: Guideline implementation, patterns of use and outcomes in daily practice in The Netherlands
Chantal W. M. van Gils et al.
ACTA ONCOLOGICA (2012)
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer
M. P. Myklebust et al.
BRITISH JOURNAL OF CANCER (2012)
Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience
S. Dighe et al.
COLORECTAL DISEASE (2012)
Cerebral Hemorrhage, Warfarin, and Intravenous tPA The Real Risk Is Not Treating
Mark J. Alberts
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
Christophe Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Understanding Optimal Colonic Cancer Surgery: Comparison of Japanese D3 Resection and European Complete Mesocolic Excision With Central Vascular Ligation
Nicholas P. West et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
Aimery de Gramont et al.
LANCET ONCOLOGY (2012)
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
U. K. Dion Morton et al.
LANCET ONCOLOGY (2012)
Extended resections for colorectal cancer - indications for supraradical lymphadenectomy
P. Hohenberger et al.
COLORECTAL DISEASE (2011)
Colon cancer incidence, presentation, treatment and outcomes over 25 years
E. Jullumstro et al.
COLORECTAL DISEASE (2011)
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
Greg Yothers et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer-A Study of CALGB 9581 and 89803
Monica M. Bertagnolli et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Ratio of Metastatic to Resected Lymph Nodes as a Prognostic Factor in Node-Positive Colorectal Cancer
Jung Wook Huh et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Improving the Quality of Colon Cancer Surgery Through a Surgical Education Program
Nicholas P. West et al.
DISEASES OF THE COLON & RECTUM (2010)
Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group
Olav Dahl et al.
ACTA ONCOLOGICA (2009)
A phase III randomised trial of LV5FU2+irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
M. Ychou et al.
ANNALS OF ONCOLOGY (2009)
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
O. Fluge et al.
BRITISH JOURNAL OF CANCER (2009)
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lymph Node Harvest in Colon Cancer: Influence of Microsatellite Instability and Proximal Tumor Location
Kjetil Soreide et al.
WORLD JOURNAL OF SURGERY (2009)
Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?
A. Berglund et al.
ANNALS OF ONCOLOGY (2008)
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nationwide quality assurance of rectal cancer treatment
A Wibe et al.
COLORECTAL DISEASE (2006)
Adjuvant chemotherapy in colorectal cancer:: A joint analysis of randomised trials by the Nordic gastrointestinal tumour adjuvant therapy group
B Glimelius et al.
ACTA ONCOLOGICA (2005)
Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination
P Jestin et al.
EUROPEAN JOURNAL OF CANCER (2005)
A systematic overview of chemotherapy effects in colorectal cancer
P Ragnhammar et al.
ACTA ONCOLOGICA (2001)
Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm
AL Martling et al.
LANCET (2000)
Share Paper
